Property | Value |
?:abstract
|
-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been recently linked to dermatologic manifestations and is thought to affect more severely patients with androgenetic alopecia. We designed a prospective multicentric study which enrolled patients from March to August of 2020 with acute telogen effluvium (ATE) that had a prior SARS-CoV-2 infection confirmed either by serological tests (e.g. detection of serum antibodies against the virus via enzyme-linked immunosorbent assays (ELISA)) or detection of viral RNA using real-time reverse transcription polymerase chain reaction (RT-PCR).
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
J_Eur_Acad_Dermatol_Venereol
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/f2b8e6f6975029bc610bdf9e0a2fdfc0cfb1e6ff.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7753386.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
|
?:type
|
|
?:year
|
|